BroadReach announces the appointment of Chris LeGrand as new global Group CEO


BroadReach announces the appointment of global healthcare, technology and development veteran, Chris LeGrand, as Group CEO, effective 1 February. Chris will take over the reins during a dynamic point of growth of the award-winning social enterprise.

‘I have been a fan of BroadReach for many years, I am honored to be working with the founders – John and Ernest, to take their vision even further’ says Chris. ‘The intersection of artificial intelligence, data, technology, coming together to advance human health is incredibly inspiring to me. I see huge growth potential across both developed and emerging economies, as we all strive to find meaningful ways to make universal health coverage a reality for everyone.’

‘This is a new and exciting era at BroadReach, and we are excited about taking the Group to the next level’, said Dr. John Sargent and Dr. Ernest Darkoh, BroadReach Co-Founders and Co-CEO’s since 2003. ‘Chris has a legacy of building strong leadership teams, successfully growing businesses, and is hugely respected within the industry.  We are confident that he will lead our business to greater heights and penetrate new markets’.  John and Ernest will continue in their roles as Co-Founders and Board members growing the Group’s work and impact on existing and new markets, and on strategic and innovation projects.

Chris is warmly welcomed by the Board and its Chairman, Michael Weintraub, venerable digital health innovator. ‘The time is now to seize the opportunity of the 4th industrial revolution (4IR) to transform the health and well-being of millions of people living in under-served communities: we have a diverse client portfolio, world-leading technology- in Vantage, committed and passionate staff, supportive investors – in PG Impact Investments – and now we have Chris to lead us into this next chapter of the BroadReach story’, says Michael Weintraub. ‘The future is bright for the social enterprise that promises to empower action and change lives.’